Skip to main content
logo
Ernexa Therapeutics Inc. (ERNA)
NASDAQ: ERNA · Real-Time Price · USD
6.06
+0.52 (9.39%)
At close: Jul 14, 2026, 4:00 PM EDT
6.09
+0.03 (0.50%)
After-hours: Jul 14, 2026, 6:40 PM EDT

Ernexa Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-11.39-14.08-44.54-21.67-24.58-122.55
Depreciation & Amortization
0.060.070.140.080.160.12
Stock-Based Compensation
1.31.51.521.242.945.24
Other Adjustments
3.025.5629.022.05-3.296
Change in Receivables
0.060.34-0.010.53-0.26-0.66
Changes in Accounts Payable
0.870.060.18-2.92.03-0.49
Changes in Unearned Revenue
---0.580.58--
Changes in Other Operating Activities
-0.75-0.45-1.56-0.331.94-1.15
Operating Cash Flow
-7.22-7.02-15.84-20.41-20.98-23.49
Capital Expenditures
--0.04-0.37-0.02-0.3-0.15
Sale of Property, Plant & Equipment
--0-0.25-
Payments for Business Acquisitions
------22.71
Proceeds from Business Divestments
-----0.12
Investing Cash Flow
--0.04-0.37-0.02-0.05-22.74
Long-Term Debt Issued
-2.255.2918--
Long-Term Debt Repaid
----1.5--0.94
Net Long-Term Debt Issued (Repaid)
-2.255.2916.5--0.94
Issuance of Common Stock
12.994.961.140.3219.7162.54
Repurchase of Common Stock
-----0.01-
Net Common Stock Issued (Repurchased)
12.994.961.140.3219.7162.54
Preferred Share Dividends Paid
----0.02-0.02-0.01
Other Financing Activities
-0.94--0.17-0.25-0.11-
Financing Cash Flow
14.517.216.2616.5619.5861.59
Net Cash Flow
7.260.16-9.94-3.87-1.4415.36
Free Cash Flow
-7.22-7.05-16.21-20.43-21.27-23.64
FCF Margin
---2784.36%-30039.70%--
Free Cash Flow Per Share
-17.40-27.96-445.19-1442.58-2614.68-4095.03
Levered Free Cash Flow
-18.31-12.22-41.46-7.76-20.76-125.17
Unlevered Free Cash Flow
-12.1-9.71-17.86-23.72-29.32-115.34
SEC Filings: 10-K · 10-Q